News & Events

Media

DEC 7, 2023
LIB Therapeutics Announces Appointment of Ingrid Choong, PhD as Chief Business Officer as Company Prepares BLA for Lerodalcibep
Read article
View PDF
nov 14, 2023
LIB Therapeutics Announces Completion of the Global Phase 3 LIBerate Program of Lerodalcibep, a Novel Third-Generation PCSK9 Inhibitor in Development for Cardiovascular Disease
Read article
View PDF
SEP 12, 2023
LIB Therapeutics and Hasten Biopharmaceutical Company Announce $325 Million StrategicCollaboration to Develop and Commercialize Lerodalcibep in Greater China
Read article
View PDF
sep 11, 2023
LIB Therapeutics Appoints David Cory as Chief Executive Officer as Lead Clinical Programs Achieve Phase 3 Completion
Read article
View PDF
AUG 28, 2023
LIB Therapeutics Announces Positive Results from the Phase 3 Long-term efficacy andsafety of Lerodalcibep in heterozygous familial hypercholesterolemia (LIBerate-HeFH) trial.
Read article
View PDF
LIBerate HeFH ESC Presentation 2023
AUG 28, 2023
View PDF
LIB003 HoFH Study - EAS Presentation 2023
may 21, 2023
View PDF
Phase 2b EAS Presentation 2020
oCT 5, 2020
View PDF
Phase 2 EAS Presentation 2019
May 27, 2019
View PDF
Phase 1 ACC Presentation 2019
June 3, 2019
View PDF
Heading
This is some text inside of a div block.

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.